In Europe, we had mixed results, many countries growing and others, quiet. At this time, it's difficult to draw any conclusions regarding the impact of financial and banking worries on the European market. It appears the market has continued to invest in better clinical capability, albeit, in a sporadic and somewhat lumpy fashion.Read the rest of this transcript for free on seekingalpha.com
Varian Medical Systems' CEO Discusses Q2 2012 Results - Earnings Call Transcript
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.